FR2677372B1 - Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques. - Google Patents

Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.

Info

Publication number
FR2677372B1
FR2677372B1 FR9106882A FR9106882A FR2677372B1 FR 2677372 B1 FR2677372 B1 FR 2677372B1 FR 9106882 A FR9106882 A FR 9106882A FR 9106882 A FR9106882 A FR 9106882A FR 2677372 B1 FR2677372 B1 FR 2677372B1
Authority
FR
France
Prior art keywords
hepatitis
nucleotide
diagnostic
peptide sequences
therapeutic applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9106882A
Other languages
English (en)
Other versions
FR2677372A1 (fr
Inventor
Christian Brechot
Dina Kremsdorf
Colette Porchon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9106882A priority Critical patent/FR2677372B1/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to CA002088666A priority patent/CA2088666A1/fr
Priority to PCT/FR1992/000501 priority patent/WO1992021759A1/fr
Priority to US07/965,285 priority patent/US5879904A/en
Priority to EP92911801A priority patent/EP0542970A1/fr
Priority to JP4510772A priority patent/JPH06500698A/ja
Publication of FR2677372A1 publication Critical patent/FR2677372A1/fr
Application granted granted Critical
Publication of FR2677372B1 publication Critical patent/FR2677372B1/fr
Priority to US08/487,231 priority patent/US5919454A/en
Priority to US09/201,912 priority patent/US6210962B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
FR9106882A 1991-06-06 1991-06-06 Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques. Expired - Lifetime FR2677372B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9106882A FR2677372B1 (fr) 1991-06-06 1991-06-06 Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
PCT/FR1992/000501 WO1992021759A1 (fr) 1991-06-06 1992-06-04 Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques
US07/965,285 US5879904A (en) 1991-06-06 1992-06-04 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
EP92911801A EP0542970A1 (fr) 1991-06-06 1992-06-04 Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques
CA002088666A CA2088666A1 (fr) 1991-06-06 1992-06-04 Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques
JP4510772A JPH06500698A (ja) 1991-06-06 1992-06-04 Ｃ型肝炎ウィルス単離物のヌクレオチド及びペプチド、診断及び治療用途
US08/487,231 US5919454A (en) 1991-06-06 1995-06-07 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
US09/201,912 US6210962B1 (en) 1991-06-06 1998-11-30 Nucleotide and peptide sequences of an isolate of the hepatitis C virus, diagnostic and therapeutic applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9106882A FR2677372B1 (fr) 1991-06-06 1991-06-06 Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.

Publications (2)

Publication Number Publication Date
FR2677372A1 FR2677372A1 (fr) 1992-12-11
FR2677372B1 true FR2677372B1 (fr) 1994-11-10

Family

ID=9413551

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9106882A Expired - Lifetime FR2677372B1 (fr) 1991-06-06 1991-06-06 Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.

Country Status (6)

Country Link
US (3) US5879904A (fr)
EP (1) EP0542970A1 (fr)
JP (1) JPH06500698A (fr)
CA (1) CA2088666A1 (fr)
FR (1) FR2677372B1 (fr)
WO (1) WO1992021759A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677372B1 (fr) 1991-06-06 1994-11-10 Pasteur Institut Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
JP3516681B2 (ja) 1991-06-24 2004-04-05 カイロン コーポレイション Ｃ型肝炎ウイルス（ｈｃｖ）ポリペプチド
US5866139A (en) * 1992-06-04 1999-02-02 Institut Pasteur Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5514539A (en) * 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US20040185061A1 (en) * 1994-07-29 2004-09-23 Innogenetics N.V. Redox reversible HCV proteins with native-like conformation
US6150134A (en) * 1994-07-29 2000-11-21 Innogenetics, N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US5674681A (en) * 1994-12-06 1997-10-07 Rothenberg; Barry E. Methods to identify hemochromatosis
US6747136B2 (en) * 1996-04-19 2004-06-08 Karolinska Innovations Ab Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
US6538114B1 (en) * 1996-04-19 2003-03-25 Karolina Innovations Ab Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
EP0947525A1 (fr) * 1998-03-27 1999-10-06 Innogenetics N.V. Epitopes de protéines d'enveloppe virale et anticorps spécifiques pour cet epitope: usage pour le diagnostic de l'antigène de virus HCV dans le tissu hÔte
US7108855B2 (en) * 1998-06-24 2006-09-19 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
KR100282147B1 (ko) * 1998-11-13 2001-02-15 구자홍 압축 영상 복원 방법
US6355425B1 (en) 1999-03-26 2002-03-12 Billups-Rothenberg, Inc. Mutations associated with iron disorders
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6858590B2 (en) * 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
CA2419418A1 (fr) * 2000-08-17 2002-02-21 Tripep Ab Vaccins contenant de la ribavirine et procedes d'utilisation associes
US7101561B2 (en) 2000-12-01 2006-09-05 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
AU2002311897A1 (en) * 2001-05-09 2002-11-18 Third Wave Technologies, Inc. Nucleic acid detection in pooled samples
KR100457790B1 (ko) * 2001-08-08 2004-12-08 충남대학교산학협력단 감염성을 갖는 ｈｃｖ 유사입자의 제조
WO2007031867A2 (fr) * 2005-05-25 2007-03-22 Tripep Ab Gene de fusion ns3/4a non structurel de l'hepatite c
WO2007111965A2 (fr) * 2006-03-22 2007-10-04 Genimmune N.V. Anticorps neutralisant le virus de l'hépatite c
CN101679512A (zh) 2007-02-21 2010-03-24 马萨诸塞州大学 抗丙型肝炎病毒（hcv）人抗体及其用途
US8071561B2 (en) * 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
US20100286070A1 (en) * 2007-09-14 2010-11-11 Gert Verheyden Affinity tag
WO2009130588A2 (fr) * 2008-04-22 2009-10-29 Tripep Ab Plateforme immunogène
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
US9402454B2 (en) 2010-04-21 2016-08-02 James Landy Fluid application device
US10550379B2 (en) 2015-06-29 2020-02-04 The Board Of Trustees Of The Leland Stanford Junior University Degron fusion constructs and methods for controlling protein production

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
CN1074422C (zh) * 1987-11-18 2001-11-07 希龙股份有限公司 制备含有hcv表位的分离多肽的方法
AU4046489A (en) * 1988-07-06 1990-02-05 Genelabs Incorporated Post-transfusion, non-a, non-b hepatitis virus and antigens
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
MC2188A1 (fr) * 1989-05-18 1992-09-16 Chiron Corp Diagnostic du nanbv:polynucleotides permettant de depister le virus de l'hepatite c
FR2677372B1 (fr) 1991-06-06 1994-11-10 Pasteur Institut Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.

Also Published As

Publication number Publication date
EP0542970A1 (fr) 1993-05-26
CA2088666A1 (fr) 1992-12-07
US6210962B1 (en) 2001-04-03
WO1992021759A1 (fr) 1992-12-10
US5919454A (en) 1999-07-06
JPH06500698A (ja) 1994-01-27
US5879904A (en) 1999-03-09
FR2677372A1 (fr) 1992-12-11

Similar Documents

Publication Publication Date Title
FR2677372B1 (fr) Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
GB2272443B (en) Nucleotide and amino acid sequences of Korean hepatitis C virus
IL123465A0 (en) 3'Terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
PT725824E (pt) Epitopos de celulas t humanas imunodominantes do virus da hepatite c
MA22905A1 (fr) Nouvelles sequences d'adn .
DE68916693D1 (de) Molekular-Diagnose von Alzheimer-Krankheit.
RU93058449A (ru) Hcv геномные последовательности для диагностических и терапевтических целей
CY2007034I1 (el) Εμβολιο εναντια στον ανθρωπινο ϊο θηλωματος (τυπος 18)
LU90911I2 (fr) Antig-ne recombinant comprenant les s-quences pre-S1 et S du virus de l'h-patite B ingr-dient actif de hepacare
AU7319194A (en) Nucleotide and amino acid sequences of the envelope 1 gene of 51 hepatitis c virus isolates and the use of reagents derived therefrom as diagnostic reagents and vaccines
GR3030811T3 (en) Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
DE69131935T2 (de) Bestimmung von DNS-Sequenzen
FR07C0023I2 (fr) Adn codant le virus du papillome de type 18 humain
CA2045323A1 (fr) Adn-c du genome du virus de l'hepatite non-a, non-b et polypeptide antigenique
DZ1706A1 (fr) Vaccin contre le virus de l'hepatite a.
FR2675064B1 (fr) Quenouille comportant une manchette resistant a l'erosion.
DE3883439D1 (de) Bestimmung von Peptidsequenzen.
EP0518313A3 (en) Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
FR2740454B1 (fr) Peptides capables d'inhiber l'endocytose de l'app et sequences nucleotidiques correspondantes
IL98273A0 (en) Dna sequences,proteins having esterase activity coded by them,and use of such proteins
AU6157996A (en) Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
IT8819791A0 (it) Peptidi ad attivita' farmaceutica.
AU1426392A (en) 5' and 3' polymerase chain reaction walking from known dna sequences
ZA916431B (en) Nucleotide and amino acid sequences of protein mtp 40 of m.tuberculosis and synthetic peptides derived therefrom
ITMI913466A1 (it) Procedimento per la depurazione dell'1, 1, 1-trifluoro-2-fluoroetano e dell'1, 1, 1-trifluoro-2, 2-dicloroetano

Legal Events

Date Code Title Description
CD Change of name or company name
CL Concession to grant licences